H. Hogan
Chief Executive Officer bij NABRIVA THERAPEUTICS PLC
Oorsprong van het eerstegraads netwerk van H. Hogan
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 12 | |
12
| Private Company | Biotechnology | 12 |
| Public Company | Biotechnology | 9 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met H. Hogan via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Director of Finance/CFO | |
Castle & Cooke, Inc.
 Castle & Cooke, Inc. HomebuildingConsumer Durables Castle & Cooke, Inc. owns and develops real estate, leases transportation equipment and manufactures brick. The firm conducts residential real estate development operations in Hawaii, Bakersfield, California, Sierra Vista, Arizona and Florida. The company was founded by Samuel Northrup Castle and Amos Starr Cooke on June 2, 1851 and is headquartered in Los Angeles, CA. | Homebuilding | Corporate Officer/Principal Corporate Officer/Principal | |
| LIGAND PHARMACEUTICALS INCORPORATED | Pharmaceuticals: Major | Founder Chief Tech/Sci/R&D Officer | |
| NEUROCRINE BIOSCIENCES, INC. | Pharmaceuticals: Major | General Counsel | |
| CUBIST PHARMACEUTICALS INC | Pharmaceuticals: Major | Director/Board Member Sales & Marketing | |
Shire ViroPharma, Inc.
 Shire ViroPharma, Inc. Pharmaceuticals: MajorHealth Technology Shire ViroPharma, Inc. develops and manufactures drugs. It offers treatment for prophylaxis of hereditary angioedema, as well as capsules for the treatment of antibiotic associated pseudomembranous colitis caused by Clostridium difficile infection (CDI) and enterocolitis. The company was founded by Claude H. Nash and Mark A. McKinlay in September 1994 and is headquartered in Exton, PA. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Director of Finance/CFO Corporate Officer/Principal | |
| The Salk Institute for Biological Studies | College/University | Director/Board Member Director/Board Member | |
DJO Global, Inc.
 DJO Global, Inc. Medical SpecialtiesHealth Technology DJO Global, Inc. engages in the development and distribution medical devices for musculoskeletal health, joint reconstruction, vascular health, and pain management. Its product include knee ligament bracing, custom bracing, post-op knee bracing, hip implants, shoulder implants, shoulder bracing, spine bracing, cervical collars, walking braces, and ankle bracing. The company was founded by Mark Nordquist and Ken Reed in 1978 and is headquartered in Lewisville, TX. | Medical Specialties | Director of Finance/CFO Director of Finance/CFO | |
Ernst & Young LLP
 Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Ernst & Young LLP engages in the provision of accounting, assurance, tax, transaction, and advisory services. It specializes in the actuarial, analytics and big data, cyber security, accounting compliance and reporting, center for board matters, international financial reporting standards, country tax advisory, global trade, tax accounting, and climate change and sustainability. The company was founded in 1989 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Comptroller/Controller/Auditor Comptroller/Controller/Auditor | |
Nabriva Therapeutics GmbH
 Nabriva Therapeutics GmbH Pharmaceuticals: MajorHealth Technology Nabriva Therapeutics GmbH is a clinical-stage biopharmaceutical company, which engages in the research and development of novel anti-infective agents to treat serious infections. It focuses on the pleuromutilin class of antibiotics. The company was founded by Rodger Novak in October 2005 and is headquartered in Vienna, Austria. | Pharmaceuticals: Major | Chief Executive Officer Chairman Director/Board Member Director/Board Member Director/Board Member Chief Tech/Sci/R&D Officer | |
| SPARK THERAPEUTICS, INC. | Biotechnology | Director of Finance/CFO Chief Tech/Sci/R&D Officer Human Resources Officer | |
| ATYR PHARMA, INC. | Pharmaceuticals: Major | Chief Executive Officer Consultant / Advisor Director of Finance/CFO | |
BIOCOM
 BIOCOM Miscellaneous Commercial ServicesCommercial Services BIOCOM provides scientific and technological services. The firm focuses that positively influence the growth of the life science industry, including capital formation, public policy, workforce development and scientific discovery and development. The company was founded in 1995 and is headquartered in San Diego, CA. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Director/Board Member | |
| San Diego State University | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
| JANUX THERAPEUTICS, INC. | Biotechnology | Director/Board Member Chairman | |
| GRITSTONE BIO, INC. | Biotechnology | Director/Board Member Director/Board Member | |
| SYNTHORX, INC. | Biotechnology | Director/Board Member Chief Executive Officer | |
| RECEPTOS INC | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| CIDARA THERAPEUTICS, INC. | Pharmaceuticals: Other | Chairman Director/Board Member | |
| Harvard Business School | College/University | Masters Business Admin Masters Business Admin | |
| SYNDAX PHARMACEUTICALS, INC. | Biotechnology | Founder Founder | |
| ARBUTUS BIOPHARMA CORPORATION | Pharmaceuticals: Major | Director/Board Member Compliance Officer | |
| University of California, Berkeley | College/University | Graduate Degree Undergraduate Degree | |
| DNIB UNWIND INC | Biotechnology | Director/Board Member Director/Board Member | |
| Rutgers State University of New Jersey | College/University | Undergraduate Degree Masters Business Admin | |
Antimicrobials Working Group
 Antimicrobials Working Group Miscellaneous Commercial ServicesCommercial Services Antimicrobials Working Group is an American nonprofit company. The firm operates as an association of antimicrobials and diagnostics companies. The company says this about itself: AWG was founded in 2012 with the vision of utilizing collective power to improve the regulatory, investment, and commercial environment for emerging infectious disease companies. Today, AWG is comprised of thirteen antimicrobials companies: Acurx Pharmaceuticals, Inc., Cidara Therapeutics Inc., CorMedix Inc., Crestone, Inc., Entasis Therapeutics Inc., Iterum Therapeutics Ltd., Melinta Therapeutics LLC, Nabriva Therapeutics US Inc., Paratek Pharmaceuticals Inc., Qpex Biopharma, Inc., SCYNEXIS Inc., UTILITY therapeutics Ltd., and Venatorx Pharmaceuticals, Inc. | Miscellaneous Commercial Services | Chairman Chairman | |
| CADENCE PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Founder | |
| Louisiana State University | College/University | Undergraduate Degree Undergraduate Degree | |
| TREVENA, INC. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
Amunix Pharmaceuticals, Inc.
 Amunix Pharmaceuticals, Inc. BiotechnologyHealth Technology Amunix Pharmaceuticals, Inc. manufactures and fabricates drugs. The firm’s pipeline products are based on proprietary XTEN half-life extension, Antibody-XTEN-Drug Conjugate, ProTIA pro-drug and bispecific T-cell engager platform technologies. The company was founded by Willem P.C. Stemmer and Volker Schellenberger in 2006 and is headquartered in Mountain View, CA. | Biotechnology | Chairman Director/Board Member | |
| VIKING THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
American Association for Cancer Research
 American Association for Cancer Research Miscellaneous Commercial ServicesCommercial Services American Association for Cancer Research prints and publishes scientific journals including clinical cancer research, molecular cancer therapeutics, molecular cancer research, cancer epidemiology, and biomarkers and prevention. The company was founded on May 7, 1907 and is headquartered in Philadelphia, PA. | Miscellaneous Commercial Services | Director/Board Member | |
American Academy of Arts & Sciences
 American Academy of Arts & Sciences Miscellaneous Commercial ServicesCommercial Services The American Academy of Arts & Sciences is an organization that honors excellence and brings together leaders. The non-profit company is based in Cambridge, MA. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Mavupharma, Inc.
 Mavupharma, Inc. Pharmaceuticals: MajorHealth Technology Mavupharma, Inc. engages development of non-nucleotide, conditional modulators of the STING pathway to treat cancer and infectious disease. The company was founded by W. Michael Gallatin, Brian K. Farmer, and Robert F. Baltera, Jr. and is headquartered in Kirkland, WA. | Pharmaceuticals: Major | Director/Board Member | |
| University of California, Los Angeles | College/University | Undergraduate Degree | |
| ENLIVEN THERAPEUTICS, INC. | Biotechnology | Chairman | |
Synchronicity Pharma, Inc.
 Synchronicity Pharma, Inc. Pharmaceuticals: OtherHealth Technology Synchronicity Pharma, Inc. discovers, develops and commercializes novel therapeutics. Its products identify components of the circadian system that can be targeted to treat metabolic and related disorders, such as diabetes, obesity, and cardiovascular diseases. The company was founded by Ross S. Bersot, Joseph S. Takahashi, Masashi Yanagisawas and Ron Evans in 2008 and is headquartered in San Jose, CA. | Pharmaceuticals: Other | Founder | |
XTuit Pharmaceuticals, Inc.
 XTuit Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology XTuit Pharmaceuticals, Inc. develops drugs for the treatment of cancer. The firm develops pharmaceutical products for use in the diagnosis and treatment of oncological, tumor and inflammatory diseases. The company was founded by Alan L. Crane, Rakesh Kumar Jain, Andrew Werk Cook, Edwin L. Steele, David H. Koch, Ronald Evans, Howard Hughes and Robert S. Langer, Jr. in 2011 and is headquartered in Waltham, MA. | Pharmaceuticals: Major | Founder | |
Mitobridge, Inc.
 Mitobridge, Inc. BiotechnologyHealth Technology Mitobridge, Inc. operates as a biopharmaceutical company. It focuses on the development and discovery of products for mitochondrial function. The firm also offers treatments for genetic, metabolic, and neurodegenerative disorders as well as diseases and conditions of aging. The company was founded by Kazumi Shiosaki, Andrew Dillin, Ronald M. Evans, Johan Auwerx and Robert H. Horvitz in October 2011 and is headquartered in Cambridge, MA. | Biotechnology | Founder | |
| PMV PHARMACEUTICALS, INC. | Miscellaneous Commercial Services | Chairman |
Statistieken
Internationaal
| Verenigde Staten | 43 |
| Oostenrijk | 2 |
| Frankrijk | 2 |
Sectoraal
| Health Technology | 29 |
| Consumer Services | 8 |
| Commercial Services | 8 |
| Consumer Durables | 2 |
| Finance | 2 |
Operationeel
| Director/Board Member | 221 |
| Corporate Officer/Principal | 83 |
| Independent Dir/Board Member | 78 |
| Chief Executive Officer | 70 |
| President | 47 |
Sterkste connecties
| Insiders | |
|---|---|
| Amir Nashat | 49 |
| Jay Lichter | 38 |
| Richard Heyman | 33 |
| Mark Corrigan | 29 |
| Vickie Capps | 27 |
| Daniel Burgess | 27 |
| Charles Rowland | 25 |
| Stephen Webster | 23 |
| James Breitmeyer | 16 |
| Theodore Schroeder | 16 |
| Jeffrey Jonker | 16 |
| Ciara Kennedy | 15 |
| John McHutchison | 14 |
| Ronald M. Evans | 14 |
| Andrew Guggenhime | 13 |
